Comparative Analysis of Disc Diffusion and E-test with Broth Micro-dilution for Susceptibility Testing of Clinical Candida Isolates Against Amphotericin B, Fluconazole, Voriconazole and Caspofungin.

BACKGROUND Antifungal susceptibility testing remains an area of intense interest because of the increasing number of clinical isolates resistant to antifungal therapy. Clinical and Laboratory Standards Institute has proposed reference broth micro dilution (BMD) method for susceptibility testing. The reference method is time-consuming and poorly suited for the routine clinical laboratory setting. Agar-based susceptibility testing methods, disk diffusion (DD) method and the E-test method can be an easier, reliable and less time consuming alternative for the BMD method. AIM To compare the results of Amphotericin B, fluconazole, voriconazole, and Caspofungin susceptibility testing by DD, and the E-test method with the CLSI reference method for clinical Candida isolates. MATERIALS AND METHODS Broth Microdilution (BMD), E-test and Disk diffusion testing of the various clinical Candida isolates was performed in accordance with CLSI documents. The results obtained were analysed and compared. RESULTS The categorical agreement for Amphotericin B, fluconazole, voriconazole, and Caspofungin susceptibility results by E-test and DD method was 65.2%, 67.4%; 100%, 82.6%; 100%, 100%; 100%, 97.8% respectively. CONCLUSION The agar-based E-test and disk diffusion methods are reliable alternatives to the BMD method for Candida isolates when test susceptible to fluconazole, voriconazole, and Caspofungin, however the susceptibility testing results must be interpreted with caution in case of Amphotericin B.

[1]  S. Bhattacharyya,et al.  Antifungal Susceptibility of Bloodstream Candida Isolates in Pediatric Patients , 2015 .

[2]  V. Khare,et al.  Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates. , 2015, Journal of clinical and diagnostic research : JCDR.

[3]  Pathak.  Antibiogram of candida species isolated from mono and multi-species oral candidal carriage using disk diffusion method , 2012 .

[4]  J. Gaudart,et al.  Interlaboratory Reproducibility of Etest Amphotericin B and Caspofungin Yeast Susceptibility Testing and Comparison with the CLSI Method , 2012, Journal of Clinical Microbiology.

[5]  Smitha Byadarahally Raju,et al.  Isolation and Identification of Candida from the Oral Cavity , 2011, ISRN dentistry.

[6]  Steven D. Brown,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement , 2008 .

[7]  S. Oliveri,et al.  Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin , 2007, Journal of Clinical Microbiology.

[8]  J. Rex,et al.  Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole , 2003, Antimicrobial Agents and Chemotherapy.

[9]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Vaneechoutte,et al.  Susceptibility Testing of Fluconazole by the NCCLS Broth Macrodilution Method, E-Test, and Disk Diffusion for Application in the Routine Laboratory , 2002, Journal of Clinical Microbiology.

[11]  M. Pfaller,et al.  Evaluation of the Etest Method for Determining Voriconazole Susceptibilities of 312 Clinical Isolates ofCandida Species by Using Three Different Agar Media , 2000, Journal of Clinical Microbiology.

[12]  A. Koç,et al.  Comparison of Etest with the broth microdilution method in susceptibility testing of yeast isolates against four antifungals. , 2000, Mycoses.

[13]  S. Redding,et al.  Fluconazole Disk Diffusion Susceptibility Testing ofCandida Species , 1998, Journal of Clinical Microbiology.

[14]  E. Anaissie,et al.  The epidemiology of hematogenous candidiasis caused by different Candida species. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Barry,et al.  Fluconazole disk diffusion procedure for determining susceptibility of Candida species , 1996, Journal of clinical microbiology.

[16]  M. Pfaller,et al.  Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose , 1996, Journal of clinical microbiology.

[17]  J. van Eldere,et al.  Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test , 1996, Journal of clinical microbiology.

[18]  M. Rinaldi,et al.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing , 1995, Journal of clinical microbiology.

[19]  M. Pfaller,et al.  Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole , 1994, Journal of clinical microbiology.

[20]  A. Espinel-Ingroff.  Etest for antifungal susceptibility testing of yeasts. , 1994, Diagnostic microbiology and infectious disease.

[21]  M. Pfaller,et al.  Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  W J Martone,et al.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.